Clinical trial

Ghrelin Effect on Beta Cell Function in Health and Disease

NCT01729299

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-04-01

PhaseNA

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2013-04-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

Exendin (9-39)DRUG

acyl ghrelinDRUG

salineDRUG

Sponsors & collaborators

David Dalessiolead sponsor

National Institutes of Health (NIH)collaborator

Mapped research locations

CincinnatiOhio, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01729299 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.